Testing effectiveness (Phase 2)Active Not RecruitingNCT00077285
What this trial is testing
Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
Who this might be right for
Sarcoma
Memorial Sloan Kettering Cancer Center 65